Atlas Trials

Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma

Clinical trial NCT01516606 · COMPLETED

Trial details

NCT number
NCT01516606
Sponsor
Andres J. M. Ferreri
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2012-01-01
Primary completion
2013-12-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.